A conversation with Anna Plym, PhD, postdoctoral fellow and prostate cancer researcher at the Harvard T.H. Chan School of Public Health, about what men can do to minimize the chance of developing prostate cancer
Nearly 10 million cancer screenings have been missed in the United States during the coronavirus pandemic, researchers report.
The investigators analyzed data on three types of cancer for which early screenings are most beneficial — breast, colon and prostate — and found that 9.4 million screenings for these cancers did not occur in the United States due to COVID-19.
If hormones are part of your treatment for breast or prostate cancer, your heart health should be closely monitored, according to a new American Heart Association scientific statement.
Hormonal therapies for breast and prostate cancer increase the risk of heart attack and stroke, the authors noted. This increased risk is greater in patients who already have two or more heart risk factors...
A nutritious diet, regular exercise and other components of a healthy lifestyle may reduce the odds of lethal prostate cancer in men with a high genetic risk for it, researchers report.
"The excess genetic risk of lethal prostate cancer could be offset by adhering to a healthy lifestyle," concluded co-lead author Anna Plym. She's a postdoctoral research fellow at Brigham and Women's Hospi...
A few years ago, Dr. Joseph Shrager, a professor of cardiothoracic surgery at Stanford University School of Medicine, noticed that lung cancer diagnoses were noticeably higher at age 65 than at slightly older or younger ages.
"There was no reason rates should differ much between the ages of 63 and 65," Shrager said.
He discussed this with his colleagues, who said they were seeing so...
Kids born to moms who took a drug widely used to prevent miscarriages in the 1950s and 1960s may be twice as likely to develop cancer in adulthood.
The drug in question, hydroxyprogesterone caproate, also known as OHPC or 17-OHPC, is a man-made version of the hormone progesterone. It is no longer used to reduce the chances of miscarriage, but it's still prescribed to prevent preterm birth...
While scientists still don't know what causes Parkinson's disease, new research shows an association between a drug that some men take for an enlarged prostate condition and a reduced risk of developing the illness.
A team led by scientists at the University of Iowa, working in collaboration with researchers in Denmark and China, found that the drug terazosin and similar medications may h...
Breast cancer has surpassed lung cancer as the world's most commonly diagnosed cancer.
In 2020, there were an estimated 19.3 million new cancer cases and nearly 10 million cancer deaths worldwide, according to the Global Cancer Statistics 2020 report from the American Cancer Society (ACS) and the International Agency for Research on Cancer.
The new year is the ideal time to focus on your health and one expert has some tips, especially for men, for doing that.
According to Dr. Kevin McVary, director of Loyola Medicine Men's Health Center, in Maywood, Ill., "Men don't always focus on their health and, in fact, men are less likely to see a doctor or utilize health resources, and wait longer than women to seek care. Often, it's ...
New research reveals an encouraging trend: Despite the rate of suicide rising overall for Americans, U.S. cancer patients are actually less likely now to take their own life than in the past.
Researchers at the American Cancer Society (ACS) tracked national data on causes of death among Americans for the years 1999 through 2018. They found "a decreasing trend of cancer-related suicide du...
As clinics closed for non-essential care and patients' COVID-19 fears kept them from check-ups, the United States saw a steep drop in cancer screenings and diagnoses during the first peak of the pandemic, a new report finds.
Researchers analyzed data on how many patients underwent cancer screening tests -- procedures such as mammograms, colonoscopies, Pap tests, PSA blood tests for prosta...
Improved lung cancer treatment is a major reason for the 31% decline in cancer death rates in the United States between 1991 and 2018, including a record 2.4% decrease from 2017 to 2018, the American Cancer Society says.
How the COVID-19 pandemic will affect this downward trend is unknown, the society noted.
"The impact of COVID-19 on cancer diagnoses and outcomes at the population ...
A cup of java may not be a bad idea for men's health: Drinking lots of coffee may reduce their risk of prostate cancer, researchers report.
The investigators analyzed data from 16 studies conducted around the world. Together, the studies involved more than a million men, about 58,000 of who went on to develop prostate cancer. The team was led by urologist Dr. Kefeng Wang, of China Medic...
If you're a Black man, your risk of getting prostate cancer is 75% higher than it is for a white man, and it's more than twice as deadly.
Now, research is helping to bring genetic risks for people of various racial and ethnic groups into focus. In doing so, dozens more risk factors that could better help pinpoint the odds of developing prostate cancer have been uncovered. And that could ...
Negative biopsies among early-stage prostate cancer patients who've chosen active surveillance are associated with a low risk of disease progression, but they aren't a sign that their cancer has completely vanished, a new study indicates.
Active surveillance refers to close monitoring for signs of cancer progression -- what's often called "watchful waiting." Patients sometimes get regula...
Hormone therapy can be a lifesaver for men with prostate cancer, but it also appears to put some at increased risk of heart problems, a new study reports.
Long-term androgen deprivation therapy (ADT) increased the risk of heart-related death nearly fourfold in a group of prostate cancer patients, and also caused their heart fitness to decrease, researchers found.
A 'watchful waiting' approach to care may be safe for Black Americans with low-risk prostate cancer, a new study suggests.
Black patients are less likely than whites to be offered watchful waiting, also called active surveillance. This may be because compared to whites, Black men are more likely to have aggressive prostate cancer and 2.4 times more likely to die from the disease.
While men can take solace in a new government report that shows prostate cancer cases have been declining overall in the past two decades, the same analysis finds that the opposite is true for advanced prostate cancer cases.
In fact, the number of cases of cancer that had already spread from the prostate to other parts of the body doubled between 2003 and 2017, going from 4% to 8&...
The coronavirus pandemic has caused many to put off medical procedures, but a delay in radiation treatment for prostate cancer doesn't appear to affect survival, a new study shows.
Researchers found that men with intermediate- or high-risk localized prostate cancer receiving radiation and hormone therapy who delay radiation while staying on hormone therapy didn't face worse outcomes....
Prostate cancer screening guidelines have been evolving for more than a decade, but new research suggests that recommendations against routine prostate cancer testing may have come at a steep price -- more men getting diagnosed with advanced prostate cancers.
The study found that rates of advanced prostate cancers rose by about 5% per year through 2016.
New treatments for melanoma have dramatically reduced deaths from this often fatal skin cancer.
Leaders of a new study report that the death rate from aggressive melanoma that spread to other organs plummeted 18% between 2013 and 2016, after jumping 7.5% between 1986 and 2013. The figures apply to white Americans, the group that accounts for nearly all cases of melanoma in th...
People with a history of certain cancers have more than double the risk for the heart rhythm disorder atrial fibrillation, a new study says.
A-fib is a common disorder that can lead to palpitations, dizziness and fatigue. Untreated, it can cause blood clots, stroke and heart failure, and people with a-fib have five times the risk of stroke than other people.
Exercise benefits prostate cancer patients who undergo hormone-reducing therapy, a small study suggests.
The treatment -- called androgen suppression therapy or androgen deprivation therapy (ADT) -- uses drugs or surgery to reduce the level of androgen hormones, which prostate cancer cells typically require to multiply.
"The problem is ADT has several side effects, including...
Adding MRI to a standard tissue biopsy appears to enhance the accuracy of a prostate cancer diagnosis, new research finds.
The study, led by researchers at the U.S. National Cancer Institute (NCI), found that combining the two methods cut the rate of "underdiagnosis" by more than half, compared to use of either MRI or biopsy alone.
Drugs that many men with prostate cancer might already be taking -- cholesterol-lowering statins -- may help extend their survival if they have a "high-risk" form of the disease, new research suggests.
High-risk patients include men with high blood levels of prostate specific antigen (PSA) and a "Gleason score" of 8 or more. Gleason scores are a calculation used to gauge prognosis in...
High levels of the sex hormone testosterone may trigger different health problems in men and women, a new study reveals.
In women, testosterone may increase the risk for type 2 diabetes, while in men it lowers that risk. But high levels of testosterone increase the risk for breast and endometrial cancer in women and prostate cancer in men, the researchers reported.
In another step toward using artificial intelligence in medicine, a new study shows that computers can be trained to match human experts in judging the severity of prostate tumors.
Researchers found that their artificial intelligence system was "near perfect" in determining whether prostate tissue contained cancer cells. And it was on par with 23 "world-leading" pathologists in judgin...
A 29% drop in U.S. cancer deaths between 1991 and 2017 was driven by declines in deaths from four major cancers -- lung, colon, breast and prostate, according to the latest American Cancer Society (ACS) annual report.
Cancer deaths in the United States fell 2.2% between 2016 and 2017, the largest-ever single-year decrease.
Here's some worrisome news for folks who manage to survive a heart attack: New research suggests they might be far more vulnerable to developing cancer down the road.
People who suffered a heart health scare -- a heart attack, heart failure or a dangerously erratic heart rhythm -- had a more than sevenfold increased risk for subsequently developing cancer, compared to those with healt...
A drug that targets faulty gene repair may buy more time for some men with advanced prostate cancer, a new clinical trial finds.
Experts called the study "landmark," because it zeroed in on men with particular gene mutations that can be targeted with newer drug therapies. It's an approach that is already used in treating breast, ovarian and lung cancers.
In the largest investigation of its kind, researchers conclude that subjecting prostate cancer patients to radiation therapy immediately after surgery doesn't give them an advantage in staying cancer-free.
The finding stems from a review of four studies that together tracked outcomes for more than 3,500 prostate cancer patients from multiple countries.
Running contrary to current guidelines, new research suggests that use of hormone-suppressing treatment over the long term may not help some men battling recurrent prostate cancer, and may even cause harm.
In fact, the study found that long-term hormone therapy was tied to a raised risk of death from other causes for some patients who received it.
In what might be a major breakthrough, researchers report that high doses of radiation dramatically prolonged survival in men battling an advanced and aggressive form of prostate cancer.
This particular type of cancer occurs when tumors resurface and spread to a number of areas beyond the prostate among patients who were in remission following radiation, surgery or chemotherapy. Gene...